skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

About Jack

USA

+3 year(s) experience

Jack Allen
Analyst Jack Allen covers the cardiovascular and metabolic markets. He provides analysis and opinion pieces on current market dynamics, treatment trends, and future pipeline development to help clients make strong, informed decisions.
As an analyst, Jack is responsible for delivering up-to-date, detailed coverage that clients can use to make informed decisions on a daily basis. To do this, he’s honed the ability to follow the general pharmaceutical industry and formulate rapid, concise opinions on a vast array of market-changing events.

Since joining Pharma Intelligence in July 2015, he has produced analysis and opinion pieces on current market dynamics, treatment trends, and future pipeline developments across cardiovascular and metabolic indications. Jack's specialties include diabetes, dyslipidemia, stroke prevention in atrial fibrillation (SPAF), venous thromboembolism (VTE), systemic hypertension, non-alcoholic steatohepatitis (NASH), and anemia induced by chemotherapy or due to chronic kidney disease.

Analyst Articles

Articles by Jack